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Cancer in American Indian and Alaska Native Young
Adults (Ages 20–44 Years): US, 1999–2004
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trol and Prevention, Atlanta, Georgia.
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BACKGROUND. An examination of cancer incidence patterns in American Indians
and Alaska Native (AI/AN) young adults may provide insight into their present
and future cancer burden.
METHODS. To reduce racial misclassification, incidence data were linked with the
Indian Health Service (IHS) patient services database. Age-adjusted cancer inci-
dence rates per 100,000 (AAR) and corresponding rate ratios (RR) for young
adults (ages 20-44 years) were compared across IHS regions and for selected can-
cers within Contract Health Service Delivery Area counties by race (AI/AN vs
non-Hispanic whites [NHW]) and sex.
RESULTS. The all-sites cancer incidence rate was lower for AI/ANs (AAR of 83.8)
than for NHWs (AAR of 111.2) (RR of 0.75) but varied by IHS regions. Among the
leading cancers in AI/AN females the risk was elevated for stomach (RR of 3.22),
colorectal (RR of 1.30), uterine (RR of 1.61), and kidney (RR of 1.39) cancers and
was lower for breast (RR of 0.70) and thyroid (RR of 0.71) cancers. Among AI/AN
young adult males the risk was elevated for stomach (RR of 2.62), liver (RR of
1.89), and kidney (RR of 1.59) cancers and lower for testicular germ cell cancer
(RR of 0.64) and lymphoma (RR of 0.60). The risk for these and other cancers var-
ied across IHS regions.
CONCLUSIONS. Many of the cancer patterns that characterize the AI/AN popula-
tion overall are apparent among young adults. Compared with NHW young
adults, the overall cancer burden among AI/AN young adults was lower but var-
ied for selected cancers and across IHS regions. Cancer control and research stra-
tegies are needed to address the unique genetic, social, cultural, and lifestyle
aspects of AI/AN young adults. Cancer 2008;113(5 suppl):1153–67. Published
2008 by the American Cancer Society.*
KEYWORDS: American Indian, Alaskan Native, cancer, incidence, surveillance,
Surveillance, Epidemiology, End Results (SEER), National Program of Cancer
Registries (NPCR).
H ealth disparities have persisted for many years among the Amer-ican Indian/Alaska Native (AI/AN) populations and other racial
and ethnic populations in the US.1-3 Although the overall cancer
burden appears lower in the AI/AN population than in other racial
and ethnic groups, the incidence and death rates for selected can-
cers, and within specific geographic regions of the US, are higher,4-7
overall cancer survival rates are lower,8,9 and cancer death rates may
be increasing for selected cancers.6,9 With more than 560 federally
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recognized tribes throughout the US, each with its own
genetic makeup, social customs, culture, and lifestyles,
these differencesmay reflect unique exposure opportu-
nities and genetic predispositions.
There are several compelling reasons for examin-
ing the cancer burden in young adults between the
ages of 20-44 years. An examination of incidence pat-
terns in this age group may foretell the future cancer
burden (because of unique and changing exposure
opportunities of young adulthood) and provide
insight into etiologic relations (because the time
since exposure and diagnosis may be somewhat
shorter in young adults than for older adults).10-12 In
particular, an analysis of incidence patterns among
the AI/AN young adult population compared with
the non-Hispanic white (NHW) young adult popu-
lation may provide insight into the present and
future disease burden in the AI/AN population and
serve as a critical first step toward describing,
monitoring, and eventually eliminating health dis-
parities.
Past efforts to characterize the burden of cancer
in the AI/AN population accurately have been hin-
dered by incomplete population coverage and racial
misclassification, thus leading to the under–reporting
of cancer incidence in the AI/AN population.
Through the efforts of the 2 federal cancer surveil-
lance programs, the Centers for Disease Control and
Prevention (CDC)’s National Program of Cancer
Registries (NPCR) and the National Cancer Institute
(NCI)’s Surveillance, Epidemiology, and End Results
(SEER) program, there are now population-based
cancer registries operating in all 50 states and the
District of Columbia. The combined coverage of the
2 federal programs now allows us to better monitor
the burden of cancer in racially, ethnically, and geo-
graphically diverse populations throughout the US,
including the many diverse AI/AN populations.13
The standard cancer registration practice of
abstracting race information directly from medical
records appears to underestimate the cancer burden
in the AI/AN population, and special methods such
as the linkage of cancer registry data to the Indian
Health Service (IHS) patient services database are
therefore required to obtain more precise esti-
mates.2,4,14 The IHS provides medical services to AI/
AN persons who are eligible members of federally
recognized tribes. Services are provided to residents
of Contract Health Service Delivery Areas (CHSDA),
counties specifically served by the IHS. Linkage of
cancer registry data to IHS records and analyses re-
stricted to CHSDA counties have helped address
issues related to the misclassification of race in the
AI/AN population.4,14
The purpose of this report is to describe cancer
incidence in the AI/AN young adult population (ages
20-44 years) and to compare it with that among
NHW young adults. This analysis is part of a larger
effort to characterize the cancer burden in the AI/AN
population as a whole by IHS regions. We anticipate
that our findings will inform cancer control planners
about the needs of this population and stimulate
research into the causes and management of cancers
in AI/AN young adults.
MATERIALS AND METHODS
Detailed descriptions of the data sources and meth-
ods used for this analysis are found in another article
in this supplement.14
Cancer Cases
Cancer incidence data for the period 1999 through
2004 were analyzed from 47 population-based regis-
tries that participate in either or both of the 2 federal
cancer surveillance programs, provided permission
for use of their data, and met data quality criteria
(see footnote in Table 1). Data were collected and
reported by use of standards established by the
North American Association of Central Cancer Regis-
tries (NAACCR).15 Primary site and histology were
coded according to the International Classification of
Diseases for Oncology (ICD-O) edition in use at the
time of diagnosis and converted to the third edi-
tion.16 For this report, cancers were categorized
according to the SEER site recodes and the SEER
modification of the third edition of the International
Classification of Childhood Cancer (ICCC-3) group-
ings.17 Because pediatric cancers tend to be dissemi-
nated at the time of diagnosis, the ICCC was
developed to better characterize these cancers by
using primarily histologic information.18 The SEER
site recodes were developed to categorize adult can-
cers by primary site in the body in which the cancer
arose (eg, digestive system, respiratory system, etc).
Cancers in adolescents and young adults include
cancers that could be characterized by both of these
coding systems.19,20 Therefore, a combination of the
2 systems was used to identify and categorize
selected cancers by use of SAS software (version 9.1;
SAS Institute Inc, Cary, NC)21 (for details see Supple-
mentary Table 1 at www.cdc/cancer-URL to be deter-
mined). Cancers defined mainly on the basis of
histology (eg, leukemia, lymphoma, melanoma, sar-
coma, etc) were put into their respective ICCC-3
categories first; the remaining cancers, which were
primarily carcinomas, were then classified by the
appropriate SEER site recodes. When possible, can-
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cers were grouped by systems (eg, digestive, genital,
endocrine, urinary, etc) and by specific cancer type
within these systems.
In this report, incidence data referred to invasive
cancers, with the exception of cancer of the urinary
bladder (bladder), which included both in situ and
invasive cancers. It should also be noted that cancer
registries throughout North America coded all pilocy-
tic astrocytoma (ICD-O-3 9421) as invasive. For con-
sistency across the period of analysis (1999-2004),
those cancers newly classified as malignant, begin-
ning in 2001 with the introduction of ICD-O-3, were
excluded. Additional changes in ICD-O-3 applied to
low malignant potential tumors of the ovary, which
were no longer coded as malignant beginning in
2001. These cancers were also excluded.
Race and Population Data and Geographic Coverage
In this report, cancer patients were classified as
‘‘American Indian’’ or ‘‘Alaska Native’’ (AI/AN) if they
were identified as such in the medical record or
through linkage with the IHS patient services data-
base. As described in detail elsewhere,4 linkages
between cancer registries and IHS records were con-
ducted by use of Link Plus,22 a probabilistic linkage
software program developed by the CDC.
County-level population estimates produced by
the US Census Bureau were used as denominators in
the rate calculations. To manage multiple race data
collected beginning in 2000, a technique of bridging
multiple race categories into single-race annual
population estimates was developed by the CDC’s
National Center for Health Statistics, in collaboration
with the Census Bureau.23 The NCI made further
refinements regarding race and county geographic
codes and provided public access to these esti-
mates24 through its SEER*Stat statistical analysis soft-
ware.25
Analyses
Averaged annual age-adjusted incidence rates per
100,000 population and 95% confidence intervals
(95% CIs) for the period 1999 through 2004 were cal-
culated by use of SEER*Stat software (version 6.3.6)25
by race and ethnicity (AI/AN, NHW), sex (males and
female), IHS regions (Alaska, East, Northern Plains,
Pacific Coast, Southern Plain, and Southwest), and
within CHSDA counties (Fig. 1). Rates were adjusted
to the 2000 US standard population by use of 5-year
age groups (20-24, 25-29, 30-34, 35-39, and 40-44
years). Rates based on case counts of <5 cases for
the entire period were italicized, and the correspond-
ing case counts and rate ratios (RRs) were sup-
pressed. CIs were constructed by use of the modified
gamma method to ensure proper coverage for small
case counts, low incidence rates, and populations
with age distributions that differ from the standard
age distribution.26
RRs and rate differences were calculated for the
purpose of comparing incidence rates between AI/
AN and NHW populations. RRs were calculated as
the age-adjusted incidence rate among the AI/AN
population divided by the age-adjusted incidence
rate among the NHW population. P values for rate
ratios used the method developed by Fay and
Feuer.27 Rate differences, which reflected either the
higher or lower rates of cancer incidence in the AI/
AN population compared with the NHW population,
were calculated by subtracting the NHW rate from
the AI/AN rate.
RESULTS
A total of 3775 incident cancer cases were diagnosed
among the AI/AN young adult population (ages 20-
44 years) in participating cancer registries during the
period between 1999 and 2004 (Table 1). A majority
of these cases (ie, 2841) representing 75.3% of all
incident cases were diagnosed among AI/AN resi-
dents of CHSDA counties. Cancer incidence rates
among AI/AN young adult CHSDA residents were
uniformly higher than rates based on AI/AN resi-
dents of all counties combined (except in Alaska,
where all counties are designated as CHSDA). In con-
trast, there was little difference in NHW rates noted
between CHSDA counties and all counties combined.
These findings are consistent with improved classifi-
cation of AI/AN cancer cases within CHSDA coun-
ties, which increased rates for AI/AN but had
minimal effect on rates for NHW. Because AI/AN
incidence rates for residents of CHSDA counties pro-
vide a more valid estimate of incidence rates for AI/
AN populations than do rates for all counties com-
bined, the remaining portion of this report will focus
solely on rates calculated for residents of CHSDA
counties.
Age-adjusted incidence rates for all cancers
combined were higher in females than for males in
both the AI/AN and NHW young adult populations
(Table 1). Rates among AI/AN young adult females
varied most across IHS regions, from a low of 76.2
per 100,000 females (East) to a high of 155.7 per
100,000 females (Southern Plains), compared with
rates among AI/AN young adult males, which ranged
from 35.7 (East) to 82.2 per 100,000 males (Southern
Plains). There was relatively little variation in rates
for NHW young adults noted across regions.
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Compared with NHW young adults, AI/AN young
adult males and females had lower all sites com-
bined incidence rates, with significantly reduced RRs
(RRs of 0.71 and 0.77, respectively), with the Pacific
Coast, East, and Southwest regions having the lowest
RRs (Table 1). In Alaska and the Southern Plains, AI/
AN young adult females had elevated cancer inci-
dence rates compared with NHW young adult
females. AI/AN young adult males had cancer inci-
dence rates that were similar to the NHW young
adult population in Alaska, the Northern Plains, and
the Southern Plains, as did AI/AN young adult
females in the Northern Plains.
Table 2 shows case counts, age-adjusted inci-
dence rates, and corresponding RRs for major cancer
groups and for specific cancers within all IHS regions
combined. Among all cancers diagnosed in AI/AN
young adult males (n 5 1006), 4 cancers accounted
for approximately 60% of all diagnoses: cancers of
the digestive system (20%), the male genital system
(18%), lymphomas (12%), and cancers of the urinary
system (9%). Cancers of the digestive system were
the leading cancers among AI/AN young adult males
in all but the Pacific Coast, where cancers of the
male genital system were most common, followed by
cancers of the digestive system (data not shown).
Among all cancers diagnosed in AI/AN young adult
females (n 5 1835), 4 cancers accounted for nearly
75% of all diagnoses: breast cancer (29%), cancers of
the female genital system (21%), the endocrine sys-
tem (12%), and the digestive system (10%). Breast
cancer was the leading cancer among AI/AN young
adult females in all IHS regions (data not shown).
Although melanoma ranked third in NHW females
and second in NHW males, accounting for 13% of
cancers in males and females combined, it was
much less common in AI/AN young adults (<4% of
incident cancers).
Specific cancers found to have statistically signif-
icantly higher incidence rates in the AI/AN young
adult population (Table 2) included: male and female
digestive system cancers (RR of 1.26), including male
and female stomach cancer (RR of 2.86); female col-
orectal cancer (CRC) (RR of 1.32); male hepatic (liver)
cancer (RR of 1.89); female genital system cancers
(RR of 1.15), including corpus uteri (uterine) cancer
(RR of 1.61); and male and female urinary system
cancers (RR of 1.28), including renal (kidney) cancer
(RR of 1.50). The largest excess, as measured by rate
differences, occurred for cancers of the digestive sys-
tem and urinary cancers in males and females and
genital cancers in females.
Specific cancers found to have statistically signif-
icantly lower incidence rates in the AI/AN young
FIGURE 1. States and Contract Health Service Delivery Areas (CHSDA) counties by Indian Health Service region.
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adult population (Table 2) included: female respira-
tory cancer (RR of 0.64), including cancer of the lung
and bronchus (RR of 0.63); male and female mela-
noma (RR of 0.20); female breast cancer (RR of 0.70);
male genital cancers (RR of 0.64), including prostate
cancer (RR of 0.51) and testicular germ cell cancer
(RR of 0.64); male and female brain and other nerv-
ous system cancers (RR of 0.66), including astrocy-
toma (RR of 0.66); male and female endocrine
cancers (RR of 0.66), including thyroid cancer (RR of
0.67); and male and female lymphoma (RR of 0.55),
including Hodgkin lymphoma (RR of 0.33) and non-
Hodgkin lymphoma (NHL) (RR of 0.69). The largest
deficits, as measured by rate differences, occurred for
female breast cancer, melanoma, testicular germ cell
cancers, and lymphoma and thyroid cancer.
Figures 2a and 2b graphically display statistically
significant log RRs from Table 2 for selected cancers
within CHSDA counties by IHS region for AI/AN
young adult males and females compared with NHW
young adult males and females.
 In Alaska, the cancer burden in AI/AN females was
higher for breast cancer and lower for melanoma.
 In the East, the cancer burden for AI/AN females
was higher for uterine cancer and lower for breast
and thyroid cancer; for AI/AN males, it was lower
for melanoma, stomach cancer, and testicular
germ cell tumors (testis).
 In the Northern Plains, the cancer burden in both
AI/AN males and females was higher for stomach
and CRC cancer and lower for melanoma.
 In the Pacific Coast, the cancer burden was higher
for Kaposi sarcoma in AI/AN males and lower for
melanoma in both males and females, NHL and
testis cancer in males, and breast and thyroid can-
cer in females.
 In the Southern Plains, the cancer burden was
higher for cervix and CRC cancers in AI/AN
females and for kidney cancer, stomach cancer,
and leukemia in males; the cancer burden was
lower for melanoma in males and females and for
testis cancer in males.
 In the Southwest, the cancer burden was higher
for kidney cancer in males and stomach and uter-
ine cancers in AI/AN females, and lower for breast,
cervix, melanoma, thyroid, and lung cancer in
females, and melanoma, NHL, testis, and lung can-
cer in males.
For all other cancers, the rate ratios among the
AI/AN and NHW young adult populations were not
statistically significantly different or data were insuf-
ficient to identify statistically significant differences.
DISCUSSION
Our analyses support earlier findings that there were
pronounced disparities in the cancer burden among
AI/AN populations and between the AI/AN and
NHW population,4 and that many of these disparities
FIGURE 2. (a and b) Statistically significant rate ratios (P < .05) to explain
the cancer burden in the American Indian/Alaskan Native young adult popu-
lation compared with the cancer burden in the non-Hispanic white population
by sex and Indian Health Service regions in individuals ages 20 to 44 years
in the US Contract Health Service Delivery Areas (CHSDA) counties, 1999
through 2004. CRC indicates colorectal cancer; NHL, non-Hodgkin lymphoma.
Source: Cancer registries in the Centers for Disease Control and Prevention’s
National Program of Cancer Registries and/or the National Cancer Institute’s
Surveillance, Epidemiology, and End Results (SEER) program. Years of data
and registries used: 1999-2004 (41 states and the District of Columbia): Ala-
bama,* Alaska,* Arizona,* Arkansas, California,* Colorado,* Connecticut,*
Delaware, District of Columbia, Florida,* Georgia, Hawaii, Idaho,* Illinois, In-
diana,* Iowa,* Kentucky, Louisiana,* Maine,* Massachusetts,* Michigan,*
Minnesota,* Missouri, Montana,* Nebraska,* Nevada,* New Hampshire, New
Jersey, New Mexico,* New York,* North Carolina,* Ohio, Oklahoma,* Oregon,*
Pennsylvania,* Rhode Island,* Texas,* Utah,* Washington,* West Virginia,
Wisconsin,* and Wyoming*; 1999 and 2002-2004: North Dakota*; 2001-
2004: South Dakota*; 2003-2004: Mississippi* and Virginia; 2004: Tennes-
see. *States with at least 1 county designated as CHSDA.
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were also apparent in the young adult population.
For example, the burden in AI/AN young adults
residing in CHSDA counties was higher for cancers
of the stomach, liver, and kidney; and lower for all
sites combined, NHL, melanoma, and cancers of the
breast, thyroid, prostate, testis, and brain. However,
these summary estimates can be misleading, as they
missed disparities that were evident only in specific
IHS regions. Because regional differences were likely
a function of the heterogeneity of AI/AN populations
with respect to genetic, social, cultural, and lifestyle
aspects, some of which are known to vary by
region,6,7,28 future analyses would benefit from routi-
nely including region-specific data.
To our knowledge, the current analysis is the first
to systematically describe the cancer burden among
AI/AN young adults between the ages of 20 and 44
years. As such, several limitations need to be
acknowledged when interpreting these results, espe-
cially as they relate to the regional data. First,
although linking cancer registry data to the IHS
patient services database and focusing the analysis
on IHS CHSDA appears to have reduced racial mis-
classification,4,14 such strategies could not correct for
misclassification among AI/AN individuals who were
not members of federally recognized tribes and as
such were not eligible for IHS services, or who did
not access IHS services. Second, because analyses
were restricted to CHSDA counties, the results can-
not be generalized to AI/AN individuals who lived
outside CHSDA, often in predominately urban areas,
and who were therefore not represented in these
rates.14 Third, the AI/AN population was small,
accounting for approximately 1% of the total US
population,29 and a diagnosis of cancer in a young
adult was a rare event. Therefore, the total number
of incident cases in AI/AN young adults in this study
was small, resulting in low statistical power to detect
differences in the cancer burden. Thus, our ability to
examine regional differences by cancer type was lim-
ited. Future analyses would benefit from expanding
coverage to include more diagnosis years and more
population-based cancer registries.
Describing the cancer burden is an essential first
step toward eliminating these disparities. There are 2
perspectives by which to view the cancer burden: a
cancer control perspective and a surveillance
research perspective. Of particular interest to cancer
control planners should be the identification of can-
cers that accounted for the majority of cancers diag-
nosed in the AI/AN young adult population (female
breast cancer, lymphoma, and cancers of the female
and male digestive, genital, and endocrine systems).
Of particular interest to researchers should be the
finding that the relative burden of selected cancers
(female breast, Kaposi sarcoma, leukemia, and can-
cers of the digestive, genital, respiratory, and urinary
systems) differed among the AI/AN populations, as
defined by IHS regions, as well as when compared
with the NHW young adult population. The leading
cancers and those with statistically significant rate
differences are discussed below.
Digestive System
Cancers of the digestive system accounted for
approximately 14% of all cancers diagnosed in AI/AN
young adults. Compared with NHW young adults,
the AI/AN population was at increased risk for stom-
ach and CRC in males and females and liver cancer
in males. Other studies have reported an elevated
risk for stomach cancer among the AI/AN popula-
tion3,30,31 and the incidence of stomach cancer may
be increasing in the AI/AN population as a whole.3
The present study confirmed an elevated risk for
stomach cancer among AI/AN young adult males in
the Northern and Southern Plains and identified
reduced risk in the East (Fig. 2a). Among AI/AN
young adult females, risk was elevated in the North-
ern Plains and the Southwest (Fig. 2b). Risk factors
for stomach cancer include infection with Helicobac-
ter pylori32 and a diet low in fruits and vegetables
and high in red meat consumption.33,34 Five-year
survival after a diagnosis of stomach cancer in the
AI/AN population was approximately 14%.8
The present study also found that AI/AN young
adult females had elevated risk for CRC in the North-
ern and Southern Plains. This finding is consistent
with a concurrent study that demonstrated wide vari-
ability in incidence rates across IHS regions, includ-
ing higher incidence rates in both AI/AN adult males
and females in Alaska and in the Northern and
Southern Plains.35 Incidence rates were also high
among younger (age <50 years) males and females
compared with older males and females, suggesting
a greater susceptibility to CRC in younger ages
among the AI/AN population than among the NHW
population.35 The incidence of CRC appears to be
increasing in the AI/AN population4,36 and risk fac-
tors thought to increase risk include personal and
family history of polyps, inflammatory bowel syn-
drome, cigarette smoking, alcohol consumption,
physical inactivity, and a diet high in animal fats and
low in fruits and vegetables.30 Infection with H.
pylori37 and diabetes38 are emerging as potential
additional risk factors for CRC. The extent to which
these risk factors can explain the variability of CRC
incidence in AI/AN young adults will require further
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research. Five-year survival after a diagnosis of CRC
in the AI/AN population was approximately 50%.8
AI/AN young adult males had a higher risk of he-
patic (liver) cancer than NHW young adult males;
however, the case counts were too small to allow cal-
culation of regional incidence rates. Elevated risk for
liver and intrahepatic bile duct cancers in the AI/AN
population has been reported elsewhere.39-41 Risk
factors for liver cancer include chronic inflammation
(cirrhosis) because of excessive alcohol consump-
tion32 or infection with hepatitis B and C (HBV and
HCV, respectively)32,42; more recently, diabetes is
emerging as a possible risk factor.43,44 In the early
1980s, infection with HBV was implicated as a lead-
ing cause of liver cancer in Alaska Native children
and adolescents, and an HBV immunization program
was instituted. As these immunized children become
young adults, rates of liver cancer may decline.45
However, more recently, liver cancer incidence has
been reported to be increasing in the general popula-
tion, attributed primarily to increased prevalence of
individuals chronically infected with the HCV.42 Mon-
itoring of incidence rates among AI/AN young adults
may help elucidate the relationship between liver
cancer and known and suspected risk factors. Five-
year survival after a diagnosis of liver cancer in the
AI/AN population was approximately 10%.8
Female Breast Cancer
Breast cancers accounted for approximately 30% of
all cancers diagnosed in AI/AN young adult women,
and breast cancer was the leading cancer diagnosed
in AI/AN women across all IHS regions. Although the
overall burden of breast cancer was lower in AI/AN
than for NHW young adult women, the burden was
not uniformly distributed across all IHS regions: the
burden was lower in the Pacific Coast, East, and
Southwest and elevated in Alaska. This distribution is
consistent with a concurrent study that has shown
wide variability in the breast cancer burden in AI/AN
women across IHS regions.46 Of particular interest is
the finding that breast cancer incidence rates have
been increasing for several decades in Alaska among
AI/AN women but not among white women.47 Differ-
ences in cancer burden among AI/AN women across
IHS regions suggest the need for research into the
role that screening, genetic factors, reproductive his-
tories (eg, parity, breast feeding, age at first full–term
pregnancy, etc), health behaviors (eg, diet and physi-
cal activity) and environmental exposures play in
them.46 Five-year survival after a diagnosis of breast
cancer in the AI/AN population was approximately
75%.8
Genital System
Cancers of the genital system accounted for approxi-
mately 14% of all cancers diagnosed in AI/AN young
adults. Cancer of the cervix uteri (cervix) accounted
for approximately 50% of all female genital system
cancers. Compared with the risk for NHW young
adult women, the risk for cancer of the cervix was
higher in the Southern Plains and lower in the
Southwest. Screening for cancer of the cervix by use
of the Papanicolaou (Pap) test is recommended for
women of all ages who have been sexually active.
Virtually all cancers of the cervix are now believed to
be associated with infection with the human papillo-
mavirus (HPV).32 An HPV vaccine has recently been
approved for use in the US for women ages 9 to 26
years30 and the vaccine offers hope for future reduc-
tion in the incidence of cancer of the cervix. In the
meantime, current incidence patterns likely reflect
differences in the prevalence of persistent HPV infec-
tion and screening activity across the IHS regions.
Prevalence estimates for recommended screening
(including the Pap test) were the lowest in the South-
ern Plains,48 the region with elevated cervical cancer
risk. Close surveillance of cervical cancer will be
necessary to ensure that high-risk populations are
reached by both screening and vaccination programs.
Five-year survival after a diagnosis of cervical cancer
in the AI/AN population was approximately 70%.8
Uterine cancer accounted for approximately 30%
of all female genital tract cancers. AI/AN young adult
women were at increased risk for corpus uteri (uter-
ine) cancer in the East and Southwest. Risk factors
for uterine cancer include elevated or prolonged ex-
posure to unopposed estrogen, including estrogen
replacement therapy, obesity, early menarche, nulli-
parity, and a history of polycystic ovary syndrome.30
The finding that AI/AN young adult women were at
elevated risk for uterine cancer is somewhat incon-
sistent with an earlier study that showed that AI/AN
women of all ages had lower uterine cancer risk than
NHW females in New Mexico.49 The extent to which
this finding reflects the geographic variability in uter-
ine cancer risk or represents a new and increasing
risk of uterine cancer in the AI/AN population
requires further investigation. Five-year survival after
a diagnosis of uterine cancer in the AI/AN popula-
tion was approximately 77%.8
Malignant germ cell tumors of the testis
accounted for approximately 90% of all male genital
cancers in this age group. The risk was uniformly
lower among AI/AN young adult males than among
NHW young adult males. Apart from a history of
undescended testicle, few if any modifiable risk fac-
tors have been identified for testis cancer.50 Testis
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cancer is often curable, as evidenced by the finding
that 5-year relative survival in AI/AN males was 90%.8
The overall burden of prostate cancer was lower
in AI/AN young adult males than in NHW young
adult males; however, the case counts were too small
to allow calculation of regional incidence rates.
Urinary System
Cancers of the urinary system accounted for approxi-
mately 5% of all cancers diagnosed in AI/AN young
adults. Compared with NHW young adult males, AI/
AN males were at elevated risk for renal (kidney) can-
cer. Other studies have reported elevated risks for kid-
ney cancer among the AI/AN population,3,30 with
some analyses reporting that the AI/AN population as
a whole has the highest rates of kidney and renal pel-
vis cancers in the US.51 The current study found that
AI/AN young adult males had an elevated risk for kid-
ney cancer in the Southern Plains and Southwest. This
finding is consistent with a concurrent study that has
shown wide variability in incidence rates for kidney
cancer across IHS regions.52 Cigarette smoking and
obesity are well-documented risk factors for kidney
cancer, whereas diets that include fruits and vegeta-
bles and physical activity may decrease risk.30 Five-
year survival after a diagnosis of kidney cancer in the
AI/AN population was approximately 66%.8
Endocrine Cancer
Cancers of the endocrine system accounted for
approximately 12% of all cancers diagnosed in AI/AN
young adult females and approximately 3% of can-
cers diagnosed in AI/AN young adult males. Essen-
tially all endocrine cancers in AI/AN young adults
were thyroid cancers. Incidence rates were uniformly
lower in AI/AN young adult females than for NHW
females. To our knowledge, apart from exposure to
ionizing radiation, little is known about risk factors
for thyroid cancer. Recent increases in thyroid cancer
incidence throughout the US may be because of
increased detection of subclinical papillary thyroid
cancer, rather than to a true increase in the inci-
dence of the cancer.53 Additional research is required
for knowing whether the lower cancer burden in the
AI/AN young adult population reflects lower incidence
of thyroid cancer or lower detection of subclinical can-
cers and, as such, was related to access to healthcare.
Five-year survival after a diagnosis of thyroid cancer in
the AI/AN population was greater than 90%.8
Lymphoma
Lymphomas accounted for less than 1% of all can-
cers diagnosed in AI/AN young adults, and NHL
accounted for the majority (65%) of these lympho-
mas. Compared with the NHW young adult popula-
tion, the overall burden of lymphoma, including
Hodgkin lymphoma and NHL, was lower in AI/AN
young adults. AI/AN young adult males had a lower
risk of NHL in the Pacific Coast and Southwest. Risk
factors for NHL include immune suppression and ex-
posure to certain infectious agents (eg, human im-
munodeficiency virus [HIV], H. pylori, etc) and
chemicals.30 Five-year survival after a diagnosis of NHL
in the AI/AN population was approximately 46%.8
Other Cancers
The overall burden of melanoma was uniformly
lower in AI/AN young adults than for NHW young
adults. Likewise, the overall burden of respiratory
cancers appeared lower in the AI/AN young adult
population than for the NHW young adult popula-
tion despite the finding that the prevalence of smok-
ing was higher overall in the AI/AN population.48
The majority of respiratory system cancers in AI/AN
young adults (88%) were cancers of the lung and
bronchus (lung). The Southwest had a statistically
significant lower lung cancer burden both in young
males and females. This finding supports the obser-
vation that current smoking prevalence estimates
(cigarette smoking being a well-established risk fac-
tor for lung cancer30) were lower in this region than
in other IHS regions.48
The burden of leukemia was elevated among AI/
AN young adult males in the Southern Plains. Risk
factors for leukemia include genetic abnormalities
(eg, Down syndrome), cigarette smoking, exposure to
chemicals, including benzene, and ionizing radiation.
Kaposi sarcoma accounted for <1% of all cancers
diagnosed in AI/AN young adults. Risk was elevated
for AI/AN young adult males in the Pacific Coast.
Kaposi sarcoma is associated with infection with
HIV.32 HIV infection was higher in AI/AN young
adults than in NHW young adults.54
Living With Cancer
The 5-year relative survival rates for many cancers of
primary importance in the AI/AN population, includ-
ing breast cancer and cancers of the digestive, geni-
tal, and urinary systems, are lower than the rates in
the NHW population.8 This finding suggests that AI/
AN males and females may have limited access to
diagnostic services or evidenced-based treatments9
including clinical trails. AI/AN males and females
also have reportedly lower participation in clinical
trials.55 Participants in clinical trials have higher edu-
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cation and income,56 whereas the AI/AN populations
as a whole have less educational attainment, lower
incomes, less insurance coverage, and less access to
personal healthcare providers.48 Even for those can-
cers with higher survival rates in the AI/AN popula-
tion (thyroid, testis, uterine), the consequence of
such a diagnosis can be great. These young males
and females have most of their potential years of life
ahead of them and, as a consequence of their diag-
nosis, may spend decades living with the physical,
reproductive, social, emotional, and spiritual effects
of a cancer diagnosis and treatment or have their
lives tragically shortened.10,11,57 A diagnosis of cancer
in a young adult is rare and healthcare practitioners
need to be aware of the unique cancer burden in
this population so that they can respond promptly
and appropriately to the first signs and symptoms of
disease.
Many of the cancer patterns that characterize
the AI/AN population overall are apparent among
young adults. Elevated risk may result from the
higher prevalence of known and suspected risk factors.
Data from the Behavioral Risk Factor Surveillance
System (BRFSS) suggests that AI/AN populations as a
whole have high prevalence of diabetes and obesity
(colorectal, kidney, liver, and uterine cancers) and
excessive alcohol (colorectal and liver cancer) and
tobacco (colorectal, kidney, and liver cancer)48 con-
sumption. In addition, the AI/AN population may be at
greater risk for infection and/or it may be infected at
an earlier age with HBV, HCV, HIV, and H. pylori than
other racial groups.53,58,59 How these risk factors oper-
ate individually or synergistically within the genetic
composition of the AI/AN population is an area for
research. In the meantime, cancer control planners
should continue to address modifiable risk factors in
the AI/AN population and in particular the young
adult population as changes in the cancer burden
because of changes in risk factor prevalence may first
become apparent in this population. In particular,
AI/AN adolescent girls and young adult females
should be receiving HPV immunization and Pap
screening, as indicated, as part of routine prevention
healthcare. Strategies for accomplishing this and
other cancer control measures must address the
unique social, cultural, and lifestyle aspects of the
AI/AN young adult population.60
Several cancers described in this report (CRC in
the Southern and Northern Plains, and Kaposi sar-
coma in the Pacific Coast) may denote sentinel
events and foretell an increasing cancer burden in
the AI/AN young adult population. The extent to
which these findings reflect the geographic variability
in cancer risk, or represent a new and increasing risk
of cancer in the AI/AN population, requires further
investigation. Monitoring of incidence rates among
AI/AN young adults may help elucidate the relation
between these cancers and known and suspected
risk factors, and such monitoring will be necessary to
ensure that high-risk populations are being reached
by cancer control efforts.
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